SARS-CoV-2 variants from mink evade inhibition by antibodies

Por um escritor misterioso

Descrição

It has been known for about a year that minks can become infected with SARS-CoV-2. The virus had been transmitted from humans to farmed mink and mutated in infected animals. Mutations were acquired in the spike protein, which is crucial for the entry of the virus into host cells and represents the central point of attack for antibodies. These SARS-CoV-2 variants from mink were transmitted back to humans, raising concerns that minks could be a continuing source of infection of humans with SARS-CoV-2 variants with altered biological properties. Researchers at the German Primate Center (DPZ) - Leibniz Institute for Primate Research in Göttingen, Germany, have now shown that an antibody used for COVID-19 therapy is unable to effectively inhibit SARS-CoV-2 harboring a spike mutation acquired in minks. In addition, the mutation reduced the inhibition of the virus by antibodies produced in SARS-CoV-2 infected humans. These results show that SARS-CoV-2 can acquire mutations in minks that may reduce control of the virus by the human immune system. The study and findings have been published in Cell Reports.
SARS-CoV-2 variants from mink evade inhibition by antibodies
Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines
SARS-CoV-2 variants from mink evade inhibition by antibodies
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
SARS-CoV-2 variants from mink evade inhibition by antibodies
Uncovering a conserved vulnerability site in SARS‐CoV‐2 by a human antibody
SARS-CoV-2 variants from mink evade inhibition by antibodies
The basis of mink susceptibility to SARS-CoV-2 infection
SARS-CoV-2 variants from mink evade inhibition by antibodies
SARS-CoV-2 Spike Protein (S1) (E5S3V) Rabbit mAb
SARS-CoV-2 variants from mink evade inhibition by antibodies
SARS-CoV-2 Variants and Vaccination – ScienceOpen
SARS-CoV-2 variants from mink evade inhibition by antibodies
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination - ScienceDirect
SARS-CoV-2 variants from mink evade inhibition by antibodies
Full article: SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies
SARS-CoV-2 variants from mink evade inhibition by antibodies
SARS-CoV-2 variant B.1.617 attacks immune system
SARS-CoV-2 variants from mink evade inhibition by antibodies
SARS-CoV-2 Variant Inhibitor Screening Kit (VANC00B)
SARS-CoV-2 variants from mink evade inhibition by antibodies
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
SARS-CoV-2 variants from mink evade inhibition by antibodies
SARS-CoV-2 Variant Protein - Elabscience
de por adulto (o preço varia de acordo com o tamanho do grupo)